Lyrica Generics Launch, But Pfizer Has Been Bracing For The Hit
Executive Summary
The first generic versions of Pfizer's blockbuster pain medicine pregabalin have launched in the US. Pfizer has guided investors the company will return to growth in 2020 after cycling through the loss.
You may also be interested in...
At Pfizer, A Split A Decade In The Making
Pfizer's ambitious plans to spin out its Upjohn branded and generics business will result in a smaller, innovation-focused pharma. The decision comes after nine years of back-and-forth about whether the move would unlock value.
Lyrica Generics Were Likely Delayed By A Pfizer Labeling Supplement
US FDA's last-minute approval may have allowed Pfizer three more weeks of sales without competition.
Lyrica Generics Likely Delayed By A Pfizer Labeling Supplement
US FDA's last-minute approval may have allowed Pfizer three more weeks of sales without competition.